K233-0879 Screening compound: N8-[2-(4-chlorophenyl)ethyl]-5-oxo-N3-(propan-2-yl)-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazoline-3,8-dicarboxamide

K233-0879 Screening compound: N8-[2-(4-chlorophenyl)ethyl]-5-oxo-N3-(propan-2-yl)-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazoline-3,8-dicarboxamide
K233-0879 Screening compound: N8-[2-(4-chlorophenyl)ethyl]-5-oxo-N3-(propan-2-yl)-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazoline-3,8-dicarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K233-0879
N8-[2-(4-chlorophenyl)ethyl]-5-oxo-N3-(propan-2-yl)-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazoline-3,8-dicarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K233-0879

Molecular Formula

C23H21ClN4O3S2 (C23 H21 ClN4 O3 S2)

Compound Name

N8-[2-(4-chlorophenyl)ethyl]-5-oxo-N3-(propan-2-yl)-1-sulfanylidene-1H,4H,5H-[1,3]thiazolo[3,4-a]quinazoline-3,8-dicarboxamide

IUPAC name

N8-[2-(4-chlorophenyl)ethyl]-5-oxo-N3-(propan-2-yl)-1-sulfanylidene-1H4H5H-[13]thiazolo[34-a]quinazoline-38-dicarboxamide

SMILES

CC(C)NC(C(SC1=S)=C(N2)N1c(cc(cc1)C(NCCc(cc3)ccc3Cl)=O)c1C2=O)=O

InChI

InChI=1S/C23H21ClN4O3S2/c1-12(2)26-22(31)18-19-27-21(30)16-8-5-14(11-17(16)28(19)23(32)33-18)20(29)25-10-9-13-3-6-15(24)7-4-13/h3-8,11-12H,9-10H2,1-2H3,(H,25,29)(H,26,31)(H,27,30)

InChI Key

GGLMVIHIBPJDDO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15083293

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

501.03

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.081

Distribution Coefficient, logD

3.081

Water Solubility, LogSw

-3.77

Polar Surface Area

74.890

Acid Dissociation Constant (pKa)

11.93

Base Dissociation Constant (pKb)

3.77

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.70

K233-0879 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Eccentric PPI Library (11937 compounds)

Lipid Metabolism Library (9174 compounds)

Protein-Protein Interaction Library (218420 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cardiovascular
  • Metabolic
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with K233-0879 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K233-0879?
Check Price and Availability of K233-0879, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K233-0879 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K233-0879
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K233-0879
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K233-0879 available by request